Julie Rubinstein

President and COO · Adaptive Biotechnologies

Julie Rubinstein (President and COO) filed 23 Form 4 reports in the trailing twelve months (0 purchases, 23 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 23 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$21.0M

shares × price, as filed

Last traded

Nov 6

Filed Nov 6

Median ADV $72.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $21.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 23 filings

Sector per market data · by filing · past 12 months

Most traded names

ADPT

Adaptive Biotechnologies Corporation ADPT · 0 buys · 24 sells 24 filings

Recent filings

ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.0M
35,643 sh across 5 lots
Exec Oct 1
Filed Oct 5 · 8:15 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $271K
19,037 sh × $14.23
Exec Apr 27
Filed Apr 29 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $798K
57,180 sh across 3 lots
Exec Apr 22
Filed Apr 24 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.0M
69,061 sh across 3 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $826K
57,180 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $675K
51,342 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $989K
68,961 sh across 3 lots
Exec Apr 6
Filed Apr 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $554K
38,120 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET More filings →